Ottavio Vitolo, MD is Consulting Chief Medical Officer of Damona Pharmaceuticals and a trained and practicing neuropsychiatrist. Prior to joining Damona, Dr. Vitolo served as Chief Medical Officer at Cerevance Therapeutics, Alcyone, and Relmada Therapeutics. Earlier in his career, Dr. Vitolo was Vice President of Clinical Development at Homology Medicines and held positions of increasing responsibility at Pfizer, including Senior Director and Head of Neuromuscular Clinical Research.

Dr. Vitolo holds a Master of Medical Sciences degree from Harvard Medical School. He received his medical degree from the University of Rome La Sapienza before completing his psychiatry residency at Washington University in St. Louis. He completed a fellowship in Behavioral Neurology and Neuropsychiatry at Brigham and Women’s Hospital and Massachusetts General Hospital.

• 

  Consulting Chief Medical Officer in DAMONA Pharmaceuticals

  Restoring cognitive functions across brain disorders